IS-40 Mutations in Interferon-g-signaling pathway, especially resulting defective-LMP2 expression, define new targets for uterine leiomyosarcoma therapy(Group5 Oncology5,International Session)
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本産科婦人科学会の論文
- 2011-02-01
著者
-
Horiuchi Akiko
Shindhu Univ. Medical School
-
Konishi Ikuo
Shindhu Univ. Medical School
-
Hayashi Takuma
Dept. of Immunology, Shinshu Univ. Grad. of School
-
Horiuchi Akiko
Dept. Of Obstetrics And Gynecology Shinshu University School Of Medicine
-
Hayashi Takuma
Dept. Of Immunology And Infectious Disease Shinshu Univ. Grad. School Of Medicine
-
Konishi Ikuo
Dept. Of Obstetrics And Gynecology Kyoto University Graduate School Of Medicine
-
Shinozawa Tanri
Dept. of Obstetrics and Gynecology, Shinshu University School of Medicine
-
Shinozawa Tanri
Dept. Of Obstetrics And Gynecology Shinshu University School Of Medicine
-
Konishi Ikuo
Dept. of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University
関連論文
- P3-IS-13 Molecular approach of uterine leiomyosarcoma tumourgenesis : involvement of defective LMP2 function(Group86 Oncology2,International Session)
- IS-40 Mutations in Interferon-g-signaling pathway, especially resulting defective-LMP2 expression, define new targets for uterine leiomyosarcoma therapy(Group5 Oncology5,International Session)
- ISP-4-1 Tumor-associated Lymphocytes Attenuate Tumor Immunity to Promote Progression of Serous Endometrial Cancer via STAT1 Pathway(Group 4 Oncology 4,IS Poster,International Session)